Search results
Results from the WOW.Com Content Network
Location. Total cost. Medicare pays. Patient pays. ambulatory surgical center. $25,669. $20,535. $5,133. hospital outpatient department. $30,408. $28,612. $1,796
Inspire is an implanted hypoglossal nerve stimulation device that treats obstructive sleep apnea by monitoring your breathing and delivering impulses to the nerve responsible for tongue movement ...
The hypoglossal nerve stimulator is a novel strategy for the treatment of obstructive sleep apnea. [ 1 ] [ 2 ] It has been gaining popularity over the last few decades and was approved in Europe in 2013 and the Food and Drug Administration (FDA) in April 2014. [ 3 ]
Medicare covers transcranial magnetic stimulation (TMS) for people who have severe major depressive disorder (MDD). You will have out-of-pocket costs.
Nerve transfers using the hypoglossal or masseteric nerves and the "babysitter" procedure result in first contractions of the mimic muscles after approximately 4 to 6 months. [4] [5] However, after the use of the hypoglossal nerve control of facial movements is hard to obtain by the patient and a spontaneous smile may not occur at all. [5]
The Centers for Medicare & Medicaid Services (CMS) is a federal agency within the United States Department of Health and Human Services (HHS) that administers the Medicare program and works in partnership with state governments to administer Medicaid, the Children's Health Insurance Program (CHIP), and health insurance portability standards.
A spinal cord stimulator (SCS) or dorsal column stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions.
A national coverage determination (NCD) [1] is a United States nationwide determination of whether Medicare will pay for an item or service. [2] It is a form of utilization management and forms a medical guideline on treatment.